| CAS登錄號 | 中文名 | 英文名 | 分子結構式 | 分子式 | 詳情 | 供應商 |
| 21693-93-6 | 1,3-Benzenedicarboxamide,N1,N3-bis[4-(4,5-dihydro-1H-imidazol-2-yl)phenyl]-5-methoxy-; 1,3-Benzenedicarboxamide,N,N'-bis[4-(4,5-dihydro-1H-imidazol-2-yl)phenyl]-5-methoxy- (9CI); Isophthalanilide, 4',4''-di-2-imidazolin-2-yl-5-methoxy- (8CI); NSC 67544 |  | C27H26N6O3 | 詳情 | 供應商 | |
| 21693-95-8 | 1,3-Benzenedicarboxamide,N1,N3-bis[4-(4,5-dihydro-1H-imidazol-2-yl)phenyl]-2-methoxy-; 1,3-Benzenedicarboxamide,N,N'-bis[4-(4,5-dihydro-1H-imidazol-2-yl)phenyl]-2-methoxy- (9CI); Isophthalanilide, 4',4''-di-2-imidazolin-2-yl-2-methoxy- (8CI) |  | C27H26N6O3 | 詳情 | 供應商 | |
| 211915-84-3 | 3-[[[2-[[(4-氰基苯基)氨基]甲基]-1-甲基-1H-苯并咪唑-5-基]羰基]吡啶-2-基氨基]丙酸乙酯; 3-[[[2-[[(4-氰基 | 3-[[[2-[[(4-Cyanophenyl)amino]methyl]-1-methyl-1H-benzimidazol-5-yl]carbonyl]pyridin-2-ylamino]propi; 3-[[[2-[[(4-Cyanophenyl)amino]methyl]-1-methyl-1H-benzimidazol-5-yl]carbonyl]pyridin-2-ylamino]propionic acid ethyl ester; Ethyl 3-(2-((4-cyanophenylamino)methyl)-1-methyl-N-(pyridin-2-yl)-1H-benzo[d]imidazole-5-carboxamido; Dabigatran Intermediate 3 |  | C27H26N6O3 | 詳情 | 供應商 |
| 1033805-22-9 | LX 1606; LX1606(1033805-22-9) HIPPURATE; (2S)-2-氨基-3-[4-[2-氨基-6-[[(1R)-1-[4-氯-2-(3-甲基吡唑-1-基)苯基]-2,2,2-三氟乙氧基]嘧啶-4-基]苯基丙酸乙酯 | LX-1606 Hippurate; LX-1606 Hippurate; LX 1606; L-Phenylalanine, 4-[2-aMino-6-[(1R)-1-[4-chloro-2-(3-Methyl-1H-pyrazol-1-yl)phenyl]-2,2,2-trifluoroethoxy]-4-pyriMidinyl]-, ethyl ester, LX-1606; Telotristat ethyl; (S)-ethyl 2-aMino-3-(4-(2-aMino-6-((R)-1-(4-chloro-2-(3-Methyl-1H-pyrazol-1-yl)phenyl)-2,2,2-trifluoroethoxy)pyriMidin-4-yl)phenyl)propanoate 2-benzaMidoacetate; (2S)-2-Amino-3-[4-[2-amino-6-[[(1R)-1-[4-chloro-2-(3-methylpyrazol-1-yl)phenyl]-2,2,2-trifluoroethyl]oxy]pyrimidin-4-yl]phenyl]propionic acid ethyl ester | 無 | C27H26ClF3N6O3 | 詳情 | 供應商 |